Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure.
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.